January 07, 2021
Spark Biomedical, a Texas-based medical device company, announced this week that the FDA has granted 510(k) clearance for its Sparrow Therapy System, a wearable neurostimulation device for the treatment of opioid withdrawal. With FDA clearance obtained, the Sparrow system is now available to U.S.…